Bambusa Therapeutics
PrivateLast Round
Series A
Extension
Nov 17, 2025
Est. Valuation
$555M
Total Funding Raised
$145M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Bambusa Therapeutics is a biotechnology company that develops bispecific antibodies for the treatment of immunological and inflammatory disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bambusa Therapeutics Comparables
Compare Bambusa Therapeutics with similar companies based on industry and business-model similarity.
Bambusa Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 17, 2025 | ||||
| Series A | Feb 14, 2025 | ||||
| Seed | Sep 9, 2024 | ||||
| Series A Extension | Nov 17, 2023 |
Bambusa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series A, Series A Extension |
| Salvia | Series A, Series A Extension, Seed |
| Janus Henderson Group | Series A, Series A Extension |
| ADAR1 Capital Management | Series A, Series A Extension |
| RA Capital Management | Series A Extension, Series A |
| Kohlberg Kravis Roberts | Series A |
| 渶策资本 | Series A, Series A Extension, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2026
Grew 18% QoQ from 17 to 20 employees.
- Apr 25, 2026
Grew 36% QoQ, from 14 to 19 employees.
Bambusa Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bambusa Therapeutics's valuation, stock price, and market status.